From January 2007 through February 2011 , a total of 21 clinical centers enrolled 608 participants , 6 months to 25 years of age ( mean [ SD ] age , 11.56.5 years in the atenolol group and 11.06.2 years in the losartan group ) , who had an aortic-root z score greater than 3.0 .